2-[2-(3-Chloro-4-methoxyphenyl)ethyl]-5-(dimethyl-1,2-oxazol-4-yl)-1-[(2S)-2-(morpholin-4-yl)propyl]-1H-1,3-benzodiazole
SGC-CBP30
CAS: 1613695-14-9
Molecular Formula: C28H33ClN4O3
2-[2-(3-Chloro-4-methoxyphenyl)ethyl]-5-(dimethyl-1,2-oxazol-4-yl)-1-[(2S)-2-(morpholin-4-yl)propyl]-1H-1,3-benzodiazole - Names and Identifiers
2-[2-(3-Chloro-4-methoxyphenyl)ethyl]-5-(dimethyl-1,2-oxazol-4-yl)-1-[(2S)-2-(morpholin-4-yl)propyl]-1H-1,3-benzodiazole - Physico-chemical Properties
| Molecular Formula | C28H33ClN4O3 |
| Molar Mass | 509.04 |
| Density | 1.28±0.1 g/cm3(Predicted) |
| Boling Point | 678.0±55.0 °C(Predicted) |
| Appearance | powder |
| Color | white to beige |
| pKa | 6.98±0.10(Predicted) |
| Storage Condition | 2-8°C |
| In vitro study | As a CREBBP/ep300-selective chemical probe, SGC-CBP30 showed moderate cytotoxicity in U2OS cells and HeLa cells. |
2-[2-(3-Chloro-4-methoxyphenyl)ethyl]-5-(dimethyl-1,2-oxazol-4-yl)-1-[(2S)-2-(morpholin-4-yl)propyl]-1H-1,3-benzodiazole - Risk and Safety
| WGK Germany | 3 |
2-[2-(3-Chloro-4-methoxyphenyl)ethyl]-5-(dimethyl-1,2-oxazol-4-yl)-1-[(2S)-2-(morpholin-4-yl)propyl]-1H-1,3-benzodiazole - Preparation solution concentration reference
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 1.964 ml | 9.822 ml | 19.645 ml |
| 5 mM | 0.393 ml | 1.964 ml | 3.929 ml |
| 10 mM | 0.196 ml | 0.982 ml | 1.964 ml |
| 5 mM | 0.039 ml | 0.196 ml | 0.393 ml |
Last Update：2024-01-02 23:10:35
![2-[2-(3-Chloro-4-methoxyphenyl)ethyl]-5-(dimethyl-1,2-oxazol-4-yl)-1-[(2S)-2-(morpholin-4-yl)propyl]-1H-1,3-benzodiazole](http://res.chembk.com/assets/str/2d/1/16/1613695-14-9.png)
Supplier List
Spot supply
Product Name: SGC-CBP30 Visit Supplier Webpage Request for quotationCAS: 1613695-14-9
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
Spot supply
Product Name: SGC-CBP30 Visit Supplier Webpage Request for quotationCAS: 1613695-14-9
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
View History